hypobromous acid has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avance, J; Brooks, N; Brown, KL; Darris, C; Fogo, A; Harris, R; Hudson, BG; Madu, H; Rose, KL; Sanchez, OA; Voziyan, P; Zhang, MZ | 1 |
Avance, J; Chetyrkin, S; Darris, C; Hudson, B; Madu, H; Rose, KL; Sanchez, OA; Voziyan, P | 1 |
2 other study(ies) available for hypobromous acid and Alloxan Diabetes
Article | Year |
---|---|
Hypohalous acids contribute to renal extracellular matrix damage in experimental diabetes.
Topics: Animals; Bromates; Diabetes Mellitus, Experimental; Extracellular Matrix; Hypochlorous Acid; Integrins; Kidney; Male; Mice; Mice, Knockout; Molecular Dynamics Simulation; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley | 2015 |
Pyridoxamine protects proteins from damage by hypohalous acids in vitro and in vivo.
Topics: Amino Acid Sequence; Animals; Bromates; Chromatography, Liquid; Collagen Type IV; Diabetes Mellitus, Experimental; Humans; Hypochlorous Acid; In Vitro Techniques; Kidney; Male; Molecular Sequence Data; Oxidants; Oxidation-Reduction; Proteolysis; Pyridoxamine; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Vitamin B Complex | 2015 |